114 related articles for article (PubMed ID: 8135749)
1. The effect of beta,beta'-tetramethylhexadecanedioic acid (MEDICA 16) on plasma very-low-density lipoprotein metabolism in rats: role of apolipoprotein C-III.
Frenkel B; Bishara-Shieban J; Bar-Tana J
Biochem J; 1994 Mar; 298 ( Pt 2)(Pt 2):409-14. PubMed ID: 8135749
[TBL] [Abstract][Full Text] [Related]
2. The hypochylomicronemic effect of beta,beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) is mediated by a decrease in apolipoprotein C-III.
Frenkel B; Mayorek N; Hertz R; Bar-Tana J
J Biol Chem; 1988 Jun; 263(17):8491-7. PubMed ID: 3372539
[TBL] [Abstract][Full Text] [Related]
3. Hypolipidemic effect of beta, beta'-tetramethyl hexadecanedioic acid (MEDICA 16) in hyperlipidemic JCR:LA-corpulent rats.
Russell JC; Dolphin PJ; Hameed M; Stewart B; Koeslag DG; Rose-Kahn G; Bar-Tana J
Arterioscler Thromb; 1991; 11(3):602-9. PubMed ID: 2029500
[TBL] [Abstract][Full Text] [Related]
4. Hypolipidemic effect of beta, beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) in normal and nephrotic rats.
Bar-Tana J; Rose-Kahn G; Frenkel B; Shafer Z; Fainaru M
J Lipid Res; 1988 Apr; 29(4):431-41. PubMed ID: 3392461
[TBL] [Abstract][Full Text] [Related]
5. MDL 29311, a phenolic antioxidant, interferes with the interaction of apoC with VLDL: a possible explanation for its triglyceride-lowering effect.
Sheetz MJ
J Lipid Res; 1995 Dec; 36(12):2609-21. PubMed ID: 8847487
[TBL] [Abstract][Full Text] [Related]
6. Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III.
Hertz R; Bishara-Shieban J; Bar-Tana J
J Biol Chem; 1995 Jun; 270(22):13470-5. PubMed ID: 7768950
[TBL] [Abstract][Full Text] [Related]
7. Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity.
Cohn JS; Patterson BW; Uffelman KD; Davignon J; Steiner G
J Clin Endocrinol Metab; 2004 Aug; 89(8):3949-55. PubMed ID: 15292332
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
[TBL] [Abstract][Full Text] [Related]
9. Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.
Chan DC; Watts GF; Nguyen MN; Barrett PH
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):590-6. PubMed ID: 16410456
[TBL] [Abstract][Full Text] [Related]
10. Hypolipidemic activity of select fibrates correlates to changes in hepatic apolipoprotein C-III expression: a potential physiologic basis for their mode of action.
Haubenwallner S; Essenburg AD; Barnett BC; Pape ME; DeMattos RB; Krause BR; Minton LL; Auerbach BJ; Newton RS; Leff T
J Lipid Res; 1995 Dec; 36(12):2541-51. PubMed ID: 8847480
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of gemfibrozil on lipoprotein metabolism.
Saku K; Gartside PS; Hynd BA; Kashyap ML
J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
[TBL] [Abstract][Full Text] [Related]
13. Adipose reduction by beta,beta'-tetramethyl-substituted hexadecanedioic acid (MEDICA 16).
Tzur R; Smith E; Bar-Tana J
Int J Obes; 1989; 13(3):313-26. PubMed ID: 2670791
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.
Aalto-Setälä K; Fisher EA; Chen X; Chajek-Shaul T; Hayek T; Zechner R; Walsh A; Ramakrishnan R; Ginsberg HN; Breslow JL
J Clin Invest; 1992 Nov; 90(5):1889-900. PubMed ID: 1430212
[TBL] [Abstract][Full Text] [Related]
15. Sensitization to insulin induced by beta,beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) in obese Zucker rats in vivo.
Mayorek N; Kalderon B; Itach E; Bar-Tana J
Diabetes; 1997 Dec; 46(12):1958-64. PubMed ID: 9392480
[TBL] [Abstract][Full Text] [Related]
16. Development of insulin resistance in the JCR:LA-cp rat: role of triacylglycerols and effects of MEDICA 16.
Russell JC; Shillabeer G; Bar-Tana J; Lau DC; Richardson M; Wenzel LM; Graham SE; Dolphin PJ
Diabetes; 1998 May; 47(5):770-8. PubMed ID: 9588449
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid cycling in the fasting rat.
Kalderon B; Mayorek N; Berry E; Zevit N; Bar-Tana J
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E221-7. PubMed ID: 10893343
[TBL] [Abstract][Full Text] [Related]
18. In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects.
Dinkel RE; Barrett PH; Demant T; Parhofer KG
Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):215-21. PubMed ID: 16580589
[TBL] [Abstract][Full Text] [Related]
19. Reduced very-low-density lipoprotein fractional catabolic rate in apolipoprotein C1-deficient mice.
Jong MC; van Ree JH; Dahlmans VE; Frants RR; Hofker MH; Havekes LM
Biochem J; 1997 Jan; 321 ( Pt 2)(Pt 2):445-50. PubMed ID: 9020879
[TBL] [Abstract][Full Text] [Related]
20. Human apolipoprotein C-III - a new intrahepatic protein factor promoting assembly and secretion of very low density lipoproteins.
Yao Z
Cardiovasc Hematol Disord Drug Targets; 2012 Dec; 12(2):133-40. PubMed ID: 23030451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
